T1	Participants 54 114	young adults with childhood-onset growth hormone deficiency.
T2	Participants 160 207	young adults with childhood-onset GH deficiency
T3	Participants 735 797	atients (n = 160; mean age, 21.2 years; 63% males) with CO GHD
